The Federal Agency for Medicines and Health Products (FAMHP) is organizing a symposium which will highlight current challenges in the development of new vaccines and the improvement of existing vaccines. The speakers will also pay attention to the role of different Belgian public institutions in bringing these vaccines to the market and to monitor their efficiency.
This event is open to a wide audience: scientists from academia and industry, health professionals, vaccine experts from regional and federal public institutions, and anyone interested in the topic of vaccination.
Participation is free of charge but requires registration using the online form.
For information and registration click here.
Morning: Discovering and developing new vaccines
09.00 am Welcome, registration and coffee
09.25 am Introduction – Xavier De Cuyper, Xavier De Cuyper, Chief Executive Officer of the Federal Agency for Medicines and Health Products (FAMHP)
09.30 am Pertussis vaccines: from whole cell to acellular vaccines and why better vaccines are still needed – Camille Locht (Institut national de la santé et de la recherche médicale – INSERM)
10.00 am Tuberculosis vaccines: rising opportunities – Johan Vekemans (World Health Organisation – WHO)
10.30 am Ebola and vaccine emergency access in Europe and western countries – Nele Berthels (FAMHP)
11.00 am Coffee break
11.30 am Quality requirement for vaccines and future perspective – Koen Brusselmans (Sciensano)
12.00 pm Shingrix as a case study to illustrate marketing authorisation procedure – Didier Hue (FAMHP)
12.30 pm FAMHP vaccine news – Stéphanie Mali (FAMHP)
12.45 pm Sandwich lunch
Afternoon: Vaccine Implementation
13.45 pm Adverse events following immunisation: from their notification to their interpretation – Françoise Wuillaume (FAMHP)
14.15 pm Implementation of vaccination program in Belgium – Paloma Carrillo (Office de la Naissance et de l’Enfance – ONE) – Geert Top (Agentschap Zorg en Gezondheild – Vlaanderen)
14.45 pm Societal impact of vaccination: beyond individual protection – Nicolas Dauby (CHU Saint-Pierre/UMC Sint-Pieter)
15.15 pm Coffee break
15.45 pm Polio eradication: what is needed to eradicate polio? Where are we now in Belgium? – Yseult Navez (Federal Public Service Health, Food Chain Safety and Environment)
16.15 pm Epidemiologic surveillance to inform and assess Belgium’s vaccine policies: strengths and challenges – Chloé Wyndham-Thomas (Sciensano)
16.45 pm Closing remarks